ALC:NYSE
Alcon AG
67,74 US$
arrow_downward
-0,12%(-0,080) 1D
21 ოქტ, 12:06:53 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
67,56 US$
High
68,09 US$
Low
67,20 US$
Mkt. cap
27,88 მლრდ.
Avg. vol.
1,77 მლნ.
Volume
429,50 ათ.
52-wk high
87,64 US$
52-wk low
61,84 US$
Beta
0,88
Shares outstanding
483,40 მლნ.
No. of employees
25 ათ.
Open
67,56 US$
High
68,09 US$
Low
67,20 US$
Mkt. cap
27,88 მლრდ.
Avg. vol.
1,77 მლნ.
Volume
429,50 ათ.
52-wk high
87,64 US$
52-wk low
61,84 US$
Beta
0,88
Shares outstanding
483,40 მლნ.
No. of employees
25 ათ.
News stories
From web sources and news partners
Investing.com UK
·
19 საათის წინ
Alcon acquires Neurotech for $550m to expand retina portfolio By Investing.com
Yahoo Finance
·
19 საათის წინ
Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
Stock Traders Daily
·
20 საათის წინ
Precision Trading with Alcon Inc. (ALC) Risk Zones
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEOდავიდ ჯეი ენდიკოტ
Employees25 ათ.
Founded1945
Headquartersჟენევა, ჟენევის კანტონი, შვეიცარია
SectorMedical device
Websitealcon.com